Transplanted liver cells can produce insulin

Key points
- Insulin is produced by islet cells in the pancreas, but scientists have been able to persuade adult liver cells to do the same thing.
- People with diabetes have been cured with transplants of islet cells, but donor islet cells are scarce.
- Ferber, from The Endocrine Institute in Tel-Hashomer, Israel, and colleagues took a gene, PDX-1, that's active in the pancreas and duodenum and transferred it to human liver cells, using a virus to carry the gene into the cells.
- As many as half the infected adult and fetal liver cells became able to store and secrete insulin, the team reports in the Proceedings of the National Academy of Sciences, Early Edition.
Insulin is produced by islet cells in the pancreas, but scientists have been able to persuade adult liver cells to do the same thing. Moreover, insulin production goes up in response to glucose levels, mimicking what happens in the body.
People with diabetes have been cured with transplants of islet cells, but donor islet cells are scarce. The possibility of using a person's own liver cells instead "may overcome the shortage in tissue availability from cadaver donors and the need for lifelong immune suppression," said Dr. Sarah Ferber.
Ferber, from The Endocrine Institute in Tel-Hashomer, Israel, and colleagues took a gene, PDX-1, that's active in the pancreas and duodenum and transferred it to human liver cells, using a virus to carry the gene into the cells.
As many as half the infected adult and fetal liver cells became able to store and secrete insulin, the team reports in the Proceedings of the National Academy of Sciences, Early Edition.
PDX-1 liver cells not only produced, stored and secreted insulin in a glucose-regulated manner, but also lessened Diabetes when implanted in diabetic mice.
The technique "represents a novel approach in tissue engineering," Ferber said. "It allows ... these tissues to acquire a new identity and function, without altering the original genetic information."
Therefore, this approach "allows the diabetic patient to be also the donor of his own therapeutic tissue," Ferber explained. However, she anticipates initial experiments in humans won't take place for several years.
SOURCE: PNAS Early Edition, May 16, 2005.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsDiabetic blindness: UVA IDs best source of stem cells to block vision loss
University of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use stem cells to block vision loss caused by diabetic retinopathy, a condition that affects millions of…
26 June 2015
NewsDefect found in pancreatic cells could lead to new diabetes treatment
A cellular defect that can impair the body's ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center (CUMC)…
9 April 2015
NewsDiabetes drug could protect against low blood sugar levels by stimulating insulin production in the body
DPP-4 inhibitors are a group of drugs used to treat type 2 diabetes that lower high blood sugar levels by stimulating insulin production in the body. Researchers at Lund University in Sweden have now discovered that…




